Rick Doblin on the FDA's MDMA Decision and the Future of Psychedelic Therapy
Timely insights from Rick Doblin on the FDA's decision on MDMA and its impact on psychedelic research and therapy in 2025.
Course curriculum
-
-
Description
-
Video Recording of Conversation with Rick Doblin
-
.png)
About this course
- Free
- 2 lessons
- 1.5 hours of video content